Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole + diethylcarbamazine + ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trial

Abstract

Registration number NCT02899936; https://clinicaltrials.gov/ct2/show/NCT02899936.